RYBREVANT® (amivantamab vmjw) plus standard of care approved in the[...]
Research Solutions Partners with OhioNet to Provide Member Libraries[...]
Research Solutions to Present and Host Investor Meetings at the 13th[...]
06/17/2021 | Press release | Distributed by Public on 06/17/2021 05:34
Please select the service you want to use:
Smartlinks | Heidelberg Pharma AG | News | Health | Healthcare Policy | Local News | Politics and Policy | Healthcare Policy | Policy and Regulation | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Public Companies | Pharmaceutical Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | BX Swiss | Tradegate Exchange | XETRA | Turquoise | Börse Hamburg | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | SIGMA X MTF | Euronext Block MTF
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact